Skip to main content
Journal cover image

Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.

Publication ,  Journal Article
Waters, RE; Kandzari, DE; Phillips, HR; Crawford, LE; Sketch, MH
Published in: Catheter Cardiovasc Interv
August 2005

Drug-eluting stent usage has become commonplace for the percutaneous treatment of de novo coronary lesions, but the safety and efficacy profile for their evolving usage in restenotic lesions is largely unknown. We report three cases of angiographically confirmed drug-eluting stent thrombosis following treatment of restenotic lesions that occurred late (193, 237, and 535 days) and shortly after interruption of antiplatelet therapy. All three patients suffered ST elevation myocardial infarction, and there was one death. Further studies are necessary to better define the associated risk and ideal duration of antiplatelet therapy necessary in this cohort of patients with restenotic lesions.

Duke Scholars

Published In

Catheter Cardiovasc Interv

DOI

ISSN

1522-1946

Publication Date

August 2005

Volume

65

Issue

4

Start / End Page

520 / 524

Location

United States

Related Subject Headings

  • Time Factors
  • Stents
  • Sirolimus
  • Postoperative Complications
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Coronary Thrombosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Waters, R. E., Kandzari, D. E., Phillips, H. R., Crawford, L. E., & Sketch, M. H. (2005). Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv, 65(4), 520–524. https://doi.org/10.1002/ccd.20428
Waters, Richard E., David E. Kandzari, Harry R. Phillips, Lawrence E. Crawford, and Michael H. Sketch. “Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.Catheter Cardiovasc Interv 65, no. 4 (August 2005): 520–24. https://doi.org/10.1002/ccd.20428.
Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv. 2005 Aug;65(4):520–4.
Waters, Richard E., et al. “Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.Catheter Cardiovasc Interv, vol. 65, no. 4, Aug. 2005, pp. 520–24. Pubmed, doi:10.1002/ccd.20428.
Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv. 2005 Aug;65(4):520–524.
Journal cover image

Published In

Catheter Cardiovasc Interv

DOI

ISSN

1522-1946

Publication Date

August 2005

Volume

65

Issue

4

Start / End Page

520 / 524

Location

United States

Related Subject Headings

  • Time Factors
  • Stents
  • Sirolimus
  • Postoperative Complications
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Coronary Thrombosis